v3.25.2
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (2,705,639) $ (5,011,141)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 17,704 173,562
Amortization of internally developed software 735,436 1,075,555
Amortization of other intangible assets 95,777 95,777
Depreciation of property and equipment 34,228 32,101
Bad debt expense 17,578 204,510
Non-cash interest income related to accretion of discount on available-for-sale securities (28,976)
Loss from sales of available-for-sale securities 680
Change in operating assets and liabilities:    
Accounts receivable – unbilled 258,906
Accounts receivable 1,054,589 (368,936)
Prepaid expenses and other current assets 59,966 54,515
Operating lease right-of-use asset 28,976 81,640
Accounts payable 117,449 279,933
Accrued expenses (523,219) (221,406)
Operating lease liability (24,282) (81,435)
Deferred revenue (196,642) (156,899)
Net cash used in operating activities (1,288,079) (3,611,614)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Capitalization of internally developed software (447,687)
Purchase of property and equipment (454) (9,136)
Purchase of available-for-sale securities (460,932)
Proceeds from sales and maturities of available-for-sale securities 3,150,320
Net cash provided by (used in) investing activities (454) 2,232,565
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of common stock in connection with At the Market Offering Agreement 1,494,414
Payment of offering costs in connection with the issuance of common stock in connection with At the Market Offering Agreement (255,288)
Payment of offering costs in connection with the on-going Public Offering (1,100)
Repurchase of common stock purchase warrants exercisable under PIPE warrants (52,500)
Net cash provided by (used in) financing activities (1,100) 1,186,626
Net decreases in cash and cash equivalents (1,289,633) (192,423)
Cash and cash equivalents at beginning of period 1,878,408 2,343,666
Cash and cash equivalents at end of period 588,775 2,151,243
Supplemental disclosure of cash flow information:    
Cash paid for interest 1,946 8,939
Supplemental disclosure of non-cash investing and financing activities:    
Non-cash amounts of lease liabilities reducing from terminating right-of-use assets 85,679
Stock issuance costs included in accounts payable and accrued expenses $ 7,023